Minimally Invasive Surgery and Chronic Pelvic Pain
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This systematic review examined minimally invasive surgical treatments for chronic pelvic pain disorders like endometriosis and pelvic adhesions, discussing their efficacy, risks, and benefits.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective: The minimally invasive surgical treatment options for many chronic pelvic pain disorders are reviewed, including treatments for endometriosis, ovarian remnant syndrome, pelvic congestion, post-ablation pain, pelvic adhesions, and uterine retroversion. Design: A systematic review of the literature referring to surgical treatments of chronic pelvic pain, with emphasis on articles published after 1990. Data Sources: Medline searches for terms including the specific chronic pain syndromes and “surgery,” “treatment,” or “management.” Eligibility Criteria: Trials, prospective and observational studies, and reviews assessing the treatment efficacy of surgical modalities employed in the treatment of chronic pelvic pain conditions were considered. Only English-language articles were included. Results: The indications, efficacy, risks, and benefits of minimally invasive treatments for each chronic pelvic pain condition are discussed. Conclusion: There are well-defined minimally invasive surgical treatment options for each chronic pelvic pain condition reviewed. There are limitations of available literature, both in level of evidence and quantity. Most studies are confounded by the multifactorial nature of chronic pelvic pain. Keywords: Minimally invasive surgery, chronic pelvic pain, laparoscopy, endometriosis, adhesions, pelvic congestion.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK